Publicacions en col·laboració amb investigadors/es de Memorial Sloan Kettering Cancer Center (11)

2009

  1. Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma

    Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Núm. 51, pp. 21830-21835

  2. Specific gene expression profiles and chromosomal abnormalities are associated with infant disseminated neuroblastoma

    BMC Cancer, Vol. 9

2007

  1. Comprehensive analysis of tumoral DNA content reveals clonal ploidy heterogeneity as a marker with prognostic significance in locoregional neuroblastoma

    Genes Chromosomes and Cancer, Vol. 46, Núm. 4, pp. 385-396

2005

  1. EMP3, a myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma

    Cancer Research, Vol. 65, Núm. 7, pp. 2565-2571

  2. Prognostic value of MYCN and ID2 overexpression in neuroblastoma

    Pediatric Blood and Cancer, Vol. 45, Núm. 7, pp. 909-915

2004

  1. Clustering of gene hypermethylation associated with clinical risk groups in neuroblastoma

    Journal of the National Cancer Institute, Vol. 96, Núm. 16, pp. 1208-1219

  2. Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21-23 in the biology of favourable stage 4 tumours

    British Journal of Cancer, Vol. 91, Núm. 6, pp. 1112-1118

  3. Positional gene expression analysis identifies 12q overexpression and amplification in a subset of neuroblastomas

    Cancer Genetics and Cytogenetics, Vol. 154, Núm. 2, pp. 131-137

  4. Rb inactivation promotes genomic instability by uncoupling cell cycle progression from mitotic control

    Nature, Vol. 430, Núm. 7001, pp. 797-802

2003

  1. Genome-wide analysis of gene expression associated with MYCN in human neuroblastoma

    Cancer Research, Vol. 63, Núm. 15, pp. 4538-4546

  2. Genomic medicine and neuroblastoma

    Expert Review of Molecular Diagnostics, Vol. 3, Núm. 1, pp. 39-54